10/7/2010 - SciQuest e–Procurement Expands Access to Axenia BioLogix Products

8/1/2010 - Axenia BioLogix Supports Homeless Veterans, Fosters Broad Employee Volunteerism

7/26/2010 - Axenia BioLogix Launches New Partnership with UCSF Cell Culture Facilities

7/1/2010 - International Serum Industry Association Elects New Board of Directors; Axenia BioLogix's CEO Reappointed as Chief Financial Officer

6/30/2010 - Axenia BioLogix Announces New Alliance with University of California


Get Adobe Reader



Back to News
7/1/2010 - International Serum Industry Association Elects New Board of Directors; Axenia BioLogix’s CEO Reappointed as Chief Financial Officer

Munich, Germany The International Serum Industry Association (ISIA) elected it new Board of Directors for 2010-2011. Axenia BioLogix CEO, Stephen Judd, was reappointed for a fourth term as the trade association’s Treasurer and Chief Financial Officer.

Founded in 2006, the ISIA is an association of collectors, processors and users of animal serum and animal-derived products. These products are used to support the growth of cells in culture and in the development and manufacturing of diagnostic kits, vaccines and biotherapeutic molecules.

“I see our participation in the ISIA as a critical component of Axenia BioLogix’s continued commitment to integrity in our industry,” stated Axenia CEO, Stephen Judd.

The mission of the ISIA is to “establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and blood products supply industry. [The ISIA focuses on the] safety and safe use of serum and animal derived products through proper origin, traceability, truth in labeling and appropriate standardization and oversight.” This mission statement and other related information is publically posted on the organization’s website at

“ISIA participation presents Axenia with a critical opportunity to interact with our competitors in a way that elevates the industry overall. We work together on many fronts, “adds Judd. “As an ISIA officer, I remain actively involved in all aspects of the association’s business. The ISIA provides a unique venue for the collaboration of key stakeholders in this industry, and I feel gratified and honored to be reappointed as CFO.”

Axenia BioLogix fosters community involvement in many different venues. Led by Axenia CEO, Stephen Judd, company employees and their families have logged hundreds of hours volunteering for national and local groups. “We are truly committed to a better world through our active involvement in the communities we touch, “says Judd.